Industry
Medical - Devices
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Loading...
Open
35.99
Mkt cap
1.5B
Volume
1.1M
High
37.44
P/E Ratio
-46.05
52-wk high
66.54
Low
35.70
Div yield
N/A
52-wk low
34.92
Portfolio Pulse from
November 29, 2024 | 5:15 pm
Portfolio Pulse from
November 20, 2024 | 6:15 pm
Portfolio Pulse from
November 08, 2024 | 1:15 am
Portfolio Pulse from Avi Kapoor
October 29, 2024 | 12:11 pm
Portfolio Pulse from Benzinga Insights
October 29, 2024 | 12:00 pm
Portfolio Pulse from Benzinga Newsdesk
October 29, 2024 | 11:51 am
Portfolio Pulse from Benzinga Insights
September 13, 2024 | 12:00 pm
Portfolio Pulse from Benzinga Newsdesk
September 13, 2024 | 10:40 am
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 4:25 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.